Ranbaxy Laboratories reports consolidated net loss of Rs 185.92 crore in Q1FY15

Ranbaxy Laboratories has reported results for first quarter ended June 30, 2014.

The company has reported net profit of Rs 755.12 crore for the quarter under review as compared to a net loss of Rs 608.80 crore for the quarter ended June 30, 2013. The company’s total income has increased by 49.96% to Rs 2204.39 crore for the quarter under review from Rs 1469.93 crore for the corresponding quarter of the previous year.

On the consolidated basis, the company has reported a net loss after taxes and Minority Interest and Share of Profit of Associates of Rs 185.92 crore for the quarter as compared to net loss of Rs 524.24 crore for the same quarter in the previous year. Besides, total income of the company has decreased by 8.16% at Rs 2451.70 crore for quarter under review as compared to Rs 2669.58 crore for the quarter ended June 30, 2013.